Terminated NA INTERVENTIONAL 2-arm NCT04558034

The Use of Cryotherapy to Prevent Paclitaxel-induced Peripheral Neuropathy and Nail Changes in Women With Breast Cancer

Sponsor: Parkview Health

Conditions Cryotherapy Effect Nail Toxicity Peripheral Neuropathy

Interventions cryotherapy

Updated 6 times since 2020 Last updated: Mar 4, 2021 Started: Aug 4, 2020 Primary completion: Feb 3, 2021 Completion: Feb 3, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Principal Investigator retired before study completed.

Listed as NCT04558034, this NA trial focuses on Cryotherapy Effect and Nail Toxicity and remains terminated or withdrawn. Sponsored by Parkview Health, it has been updated 6 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Apr 2021 — Jul 2024 [monthly]

Terminated NA

Status: Recruiting → Terminated
Mar 2021 — Apr 2021 [monthly]

Recruiting NA
Jan 2021 — Mar 2021 [monthly]

Recruiting NA

▶ Show 1 earlier version

Oct 2020 — Jan 2021 [monthly]

Recruiting NA

First recorded

Aug 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Parkview Health

Data source: Parkview Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Fort Wayne, United States